Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for human lung cancers

S G Swisher1, J A Roth

  • 1Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Surgical Oncology Clinics of North America
|June 13, 1998
PubMed
Summary

Gene therapy shows promise for future lung cancer treatment, with early trials confirming safety. Current challenges include temporary gene expression and targeted delivery methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis.

Oncogene·1998
Same author

Increased MHC class II and CD25 expression on lymphocytes in the absence of persistent lymphocytosis in cattle experimentally infected with bovine leukemia virus.

Veterinary immunology and immunopathology·1998
Same author

Effects of long-term infection with bovine immunodeficiency virus and/or bovine leukemia virus on antibody and lymphocyte proliferative responses in cattle.

Veterinary immunology and immunopathology·1998
Same author

Viral and nonviral gene delivery vectors for cancer gene therapy.

Cancer detection and prevention·1998
Same author

Immunology and prevention of infection in feedlot cattle.

The Veterinary clinics of North America. Food animal practice·1998
Same author

Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.

Seminars in oncology·1998

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Gene therapy presents a novel therapeutic avenue for managing various lung malignancies.
  • Existing gene transfer methods face limitations in efficacy and safety.

Purpose of the Study:

  • To explore the potential of gene therapy in treating lung cancer.
  • To review the current safety data from early-phase clinical trials.
  • To identify the key challenges hindering the clinical application of gene therapy for lung cancer.

Main Methods:

  • Review of existing literature on gene therapy for lung cancer.
  • Analysis of safety data from Phase I clinical trials.
  • Evaluation of current gene transfer techniques and their limitations.

Main Results:

  • Phase I trials indicate that gene therapy approaches are generally safe for lung cancer patients.
  • Transient gene expression is a significant limitation, affecting long-term therapeutic outcomes.
  • Challenges in locoregional delivery and safe, targeted tumor delivery persist.

Conclusions:

  • Gene therapy holds future potential for lung cancer treatment, pending further research.
  • Overcoming limitations in gene expression duration and delivery methods is crucial for clinical success.
  • Continued investigation into advanced gene transfer techniques is warranted.

Related Experiment Videos